Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study

医学 镭-223 前列腺癌 肿瘤科 危险系数 N-末端末端肽 吡啶 前瞻性队列研究 骨重建 内科学 比例危险模型 骨吸收 前列腺特异性抗原 置信区间 泌尿科 癌症 骨转移 碱性磷酸酶 骨钙素 生物化学 化学 酶
作者
Nuria Romero-Laorden,David Lorente,Guillermo de Velasco,Rebeca Lozano Mejorada,Bernardo Herrera‐Imbroda,Javier Puente,Pedro Pablo Lopez-Casas,Ana Medina,Elena Almagro,Enrique González‐Billalabeitia,Jose Carlos Villla-Guzman,Aranzazu González del Alba,Pablo Borrega,Núria Laínez,Ana Fernández-Freire,Amaia Hernández,Alejo Rodríguez‐Vida,Isabel Chirivella,E. Fernández-Parra,Fernando López‐Campos
出处
期刊:European Urology Oncology [Elsevier BV]
卷期号:7 (3): 447-455 被引量:20
标识
DOI:10.1016/j.euo.2023.09.015
摘要

Background Radium-223 is an active therapy option for bone metastatic castration-resistant prostate cancer (mCRPC). The lack of adequate biomarkers for patient selection and response assessment are major drawbacks for its use. Objective To assess the prognostic value of bone metabolism biomarkers (BMBs) in ra-223–treated mCRPC patients. Design, setting, and participants A prospective cohort study of mCRPC patients treated with Ra-223 (PRORADIUM study: NCT02925702) was conducted. Outcome measurements and statistical analysis The main objective of the study was to evaluate the association between high (≥median) baseline values in at least three bone formation (bone alkaline phosphatase [BAP] and C-terminal type-I collagen propeptide) and bone resorption (N-terminal telopeptide and pyridinoline) biomarkers, and survival. The independent prognostic value of each BMB was also assessed. The association with time to radiographic, clinical, and prostate-specific antigen (PSA) progression; time to skeletal-related events; and PSA response were secondary objectives. Multivariable (MV) Cox-regression models were evaluated. Results and limitations A total of 169 patients were included. Of the patients, 70.4% received Ra-223 in second/third line; 144 (85.2%) were Eastern Cooperative Oncology Group 0–1, 126 (74.6%) were in pain, and 80 (47.5%) had more than ten bone metastases. Sixty-seven (39.6%) patients had elevation in at least three BMBs. The median overall survival was 12.1 mo (95% confidence interval [CI]: 10–14.7). No association was observed with other treatment-related secondary outcome parameters. Patients with high values in three or more BMBs had significantly worse survival (9.9 vs 15.2 mo; hazard ratio [HR]: 1.8 [95% CI: 1.3–2.5]; p < 0.001) in the univariate analysis, but not independent in the MV analysis (HR: 1.33; 95% CI: 0.89–2; p = 0.181). High baseline BAP was the only biomarker associated with survival in the MV model (HR: 1.89; 95% CI: 1.28–2.79; p = 0.001). Addition of BAP to the MV clinical model increased the area under the receiver operating characteristic curve 2-yr value from 0.667 to 0.755 (p = 0.003). Conclusions Biomarkers of bone formation, especially BAP, have prognostic value in mCRPC patients treated with radium-223. Its predictive value remains to be assessed, ideally in prospective, adequately powered, randomised clinical trials. Patient summary In this study, we evaluate the role of bone metabolism biomarkers to help improve the use of radium-223 as therapy for advanced prostate cancer. We found that bone alkaline phosphatase may be a suitable tool.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小二郎的应助被LGL采纳,获得10
刚刚
Akim的应助被科研通管家采纳,获得10
刚刚
充电宝的应助被科研通管家采纳,获得10
刚刚
1秒前
Hello的应助被科研通管家采纳,获得10
1秒前
咘鹿咘噜发布了新的文献求助20
1秒前
我是老大的应助被科研通管家采纳,获得10
1秒前
华仔的应助被科研通管家采纳,获得10
1秒前
隐形曼青的应助被科研通管家采纳,获得10
1秒前
鲨鱼辣椒完成签到,获得积分10
1秒前
桐桐的应助被科研通管家采纳,获得10
1秒前
丘比特的应助被科研通管家采纳,获得10
1秒前
打打的应助被科研通管家采纳,获得10
1秒前
顾矜的应助被科研通管家采纳,获得10
2秒前
2秒前
大个的应助被科研通管家采纳,获得10
2秒前
在水一方的应助被科研通管家采纳,获得10
2秒前
今后的应助被科研通管家采纳,获得10
2秒前
飞天小女警完成签到,获得积分10
2秒前
Maestro_S的应助被科研通管家采纳,获得10
2秒前
syvshc的应助被勇勇采纳,获得10
2秒前
婷婷小笑的应助被科研通管家采纳,获得10
2秒前
清洁能源动力驴完成签到,获得积分10
2秒前
我是老大的应助被科研通管家采纳,获得10
3秒前
3秒前
脑洞疼的应助被科研通管家采纳,获得10
3秒前
Lucas的应助被科研通管家采纳,获得10
3秒前
Hello的应助被科研通管家采纳,获得10
3秒前
赘婿的应助被科研通管家采纳,获得10
3秒前
冷酷以山的应助被科研通管家采纳,获得10
3秒前
molihuakai的应助被科研通管家采纳,获得10
3秒前
4秒前
思源的应助被科研通管家采纳,获得10
4秒前
田様的应助被科研通管家采纳,获得10
4秒前
4秒前
4秒前
4秒前
领导范儿的应助被科研通管家采纳,获得10
4秒前
4秒前
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192078
求助须知:如何正确求助?哪些是违规求助? 9578698
关于积分的说明 21861559
捐赠科研通 7791583
什么是DOI,文献DOI怎么找? 3436814
关于科研通互助平台的介绍 2560538
邀请新用户注册赠送积分活动 2483582